Oncolytic virus therapy for mesothelioma - a phase I trial of intrapleural seprehvir

被引:0
|
作者
Woll, P. J. [1 ]
Danson, S. J. [1 ]
Edwards, J. G. [1 ]
Fisher, P. M. [1 ]
Conner, J. [1 ]
机构
[1] Univ Sheffield, Sheffield Teaching Hosp & Virttu Biol, Sheffield S10 2TN, S Yorkshire, England
关键词
D O I
10.1016/S0169-5002(13)70098-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
98
引用
收藏
页码:S34 / S34
页数:1
相关论文
共 50 条
  • [1] Oncolytic virus therapy for mesothelioma - a phase I trial proposal
    Woll, P. J.
    Edwards, J. G.
    Danson, S.
    Fisher, P. M.
    Matthews, S.
    Conner, J.
    LUNG CANCER, 2009, 63 : S26 - S27
  • [2] Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716
    Danson, Sarah J.
    Conner, Joe
    Edwards, John G.
    Blyth, Kevin G.
    Fisher, Patricia M.
    Muthana, Munitta
    Salawu, Abdulazeez
    Taylor, Fiona
    Hodgkinson, Elizabeth
    Joyce, Patrick
    Roman, Jennifer
    Simpson, Kathleen
    Graham, Alexander
    Learmonth, Kirsty
    Woll, Penella J.
    LUNG CANCER, 2020, 150 : 145 - 151
  • [3] ONCOLYTIC HERPES VIRUS THERAPY FOR MESOTHELIOMA- A PHASE I STUDY OF INTRAPLEURAL ONCOLYTIC VIRUS HSV1716 (NCT01721018)
    Woll, Penella
    Danson, Sarah
    Edwards, John
    Goldsborough, Susan
    Fisher, Patricia
    Conner, Joe
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S940 - S941
  • [4] Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR® in patients with malignant pleural mesothelioma
    Learmonth, Kirsty
    Braidwood, Lynne
    Woll, Penella
    Conner, Joe
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [5] Oncolytic herpesvirus therapy for mesothelioma: A phase I/IIa trial of intrapleural administration of HSV1716 (NCT01721018)
    Danson, S.
    Woll, P.
    Edwards, J.
    Blyth, K.
    Fisher, P.
    Roman, J.
    Simpson, K.
    Spavin, R.
    Learmonth, K.
    Conner, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma
    Chintala, Navin K.
    Choe, Jennie K.
    McGee, Erin
    Bellis, Rebecca
    Saini, Jasmeen K.
    Banerjee, Srijita
    Moreira, Andre L.
    Zauderer, Marjorie G.
    Adusumilli, Prasad S.
    Rusch, Valerie W.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] HSV1716 (SEPREHVIR): AN ONCOLYTIC HERPES VIRUS FOR CANCER THERAPY
    Braidwood, Lynne
    ANTICANCER RESEARCH, 2014, 34 (10) : 5844 - 5844
  • [8] PRELIMINARY RESULTS - "A PHASE I TRIAL OF ONCOLYTIC MEASLES VIROTHERAPY IN MESOTHELIOMA" INVESTIGATING THE INTRAPLEURAL ADMINISTRATION OF THE MODIFIED VACCINE STRAIN MEASLES VIRUS (MV-NIS) TO PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
    Peikert, Tobias
    Molina, Julian
    Aderca, Ileana
    Albelda, Stephen
    Carlson, Stephanie
    Lowe, Val
    Maldonado, Fabien
    Mandrekar, Sumithra
    Patel, Manish
    Roden, Anja
    Van Keulen, Virginia
    Kratzke, Robert
    Galanis, Evanthia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S640 - S640
  • [9] INTRAPLEURAL PHOTODYNAMIC THERAPY - RESULTS OF A PHASE-I TRIAL
    PASS, HI
    DELANEY, TF
    TOCHNER, Z
    SMITH, PE
    TEMECK, BK
    POGREBNIAK, HW
    KRANDA, KC
    RUSSO, A
    FRIAUF, WS
    COLE, JW
    MITCHELL, JB
    THOMAS, G
    ANNALS OF SURGICAL ONCOLOGY, 1994, 1 (01) : 28 - 37
  • [10] Recombinant adenoviral-mediated mediate intrapleural gene therapy for malignant mesothelioma: Preliminary findings of a phase I clinical trial
    Sterman, DH
    Elshami, AA
    Kucharczuk, JC
    Rizk, NP
    Kumar, V
    Wood, J
    Wilson, JM
    MolnarKimber, K
    Litzky, LA
    Kaiser, LR
    Roberts, JR
    Recio, A
    Treat, J
    Albelda, SM
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A280 - A280